| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Cambridge Investment Research Publicly Traded Securities | 694,803 | 630,968 | 63,835 | |||||||
| Charles Schwab Publicly Traded Securities | 93,344 | 78,070 | 15,274 | |||||||
| Cambridge Investment Research Capital Gain Distributions | 4,485 | 4,485 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Provision Financial Investment | 1,119,084 | 1,195,255 | |
| Charles Schwab Investment | 11,218 | 9,992 |
| Description | Amount |
|---|---|
| Adjustments such as wash sales, corporate actions and div reclassification | 175 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Cambridge Investment Research Other Income | 1,110 | 1,110 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Cambridge Investment Research Investment Advisor | 17,531 | |||
| Charles Schwab Investment Advisor | 483 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise Tax | 237 | 237 |